These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26820383)

  • 1. Type of Atrial Fibrillation and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Shaul AA; Kornowski R; Bental T; Vaknin-Assa H; Assali A; Golovchiner G; Kadmon E; Codner P; Orvin K; Strasberg B; Barsheshet A
    Ann Noninvasive Electrocardiol; 2016 Sep; 21(5):519-25. PubMed ID: 26820383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
    Hengstenberg C; Chandrasekhar J; Sartori S; Lefevre T; Mikhail G; Meneveau N; Tron C; Jeger R; Kupatt C; Vogel B; Farhan S; Sorrentino S; Sharma M; Snyder C; Husser O; Boekstegers P; Hambrecht R; Widder J; Hildick-Smith D; De Carlo M; Wijngaard P; Deliargyris E; Bernstein D; Baber U; Mehran R; Anthopoulos P; Dangas G;
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1027-1037. PubMed ID: 28493641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial.
    Biviano AB; Nazif T; Dizon J; Garan H; Fleitman J; Hassan D; Kapadia S; Babaliaros V; Xu K; Parvataneni R; Rodes-Cabau J; Szeto WY; Fearon WF; Dvir D; Dewey T; Williams M; Mack MJ; Webb JG; Miller DC; Smith CR; Leon MB; Kodali S
    Circ Cardiovasc Interv; 2016 Jan; 9(1):e002766. PubMed ID: 26733582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doppler Mean Gradient Is Discordant to Aortic Valve Calcium Scores in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Alkurashi AK; Pislaru SV; Thaden JJ; Collins JD; Foley TA; Greason KL; Eleid MF; Sandhu GS; Alkhouli MA; Asirvatham SJ; Cha YM; Williamson EE; Crestanello JA; Pellikka PA; Oh JK; Nkomo VT
    J Am Soc Echocardiogr; 2022 Jan; 35(1):116-123. PubMed ID: 34506919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    Jaakkola J; Jaakkola S; Airaksinen KEJ; Husso A; Juvonen T; Laine M; Virtanen M; Maaranen P; Niemelä M; Mäkikallio T; Savontaus M; Tauriainen T; Valtola A; Vento A; Eskola M; Raivio P; Biancari F
    PLoS One; 2020; 15(9):e0238953. PubMed ID: 32915895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management.
    Megaly M; Garcia S; Anzia LE; Morley P; Garberich R; Gornick CC; Lesser J; Sorajja P; Gössl M; Sengupta J
    J Invasive Cardiol; 2019 Jul; 31(7):E177-E183. PubMed ID: 31257211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials.
    Brener MI; George I; Kosmidou I; Nazif T; Zhang Z; Dizon JM; Garan H; Malaisrie SC; Makkar R; Mack M; Szeto WY; Fearon WF; Thourani VH; Leon MB; Kodali S; Biviano AB
    J Am Heart Assoc; 2021 Apr; 10(7):e019584. PubMed ID: 33754803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial Fibrillation and Outcomes After Transcatheter or Surgical Aortic Valve Replacement (from the PARTNER 3 Trial).
    Shahim B; Malaisrie SC; George I; Thourani VH; Biviano AB; Russo MJ; Brown DL; Babaliaros V; Guyton RA; Kodali SK; Nazif TM; McCabe JM; Williams MR; Généreux P; Lu M; Yu X; Alu MC; Webb JG; Mack MJ; Leon MB; Kosmidou I
    Am J Cardiol; 2021 Jun; 148():116-123. PubMed ID: 33691183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
    Tanawuttiwat T; Stebbins A; Marquis-Gravel G; Vemulapalli S; Kosinski AS; Cheng A
    J Am Heart Assoc; 2022 Jan; 11(1):e023561. PubMed ID: 34970918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
    Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sinus rhythm versus atrial fibrillation on left ventricular remodeling after transcatheter aortic valve replacement.
    Ledwoch J; Fröhlich C; Olbrich I; Poch F; Thalmann R; Fellner C; Bradaric C; Laugwitz KL; Kupatt C; Hoppmann P
    Clin Res Cardiol; 2021 May; 110(5):689-698. PubMed ID: 33566184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter Aortic Valve Replacement and Atrial Fibrillation: Impact of Antithrombotic Strategy on Clinical Outcomes.
    Hui S; Gooley R; Rashid HN; Zaman S
    Heart Lung Circ; 2019 May; 28(5):771-776. PubMed ID: 29691157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.